|
Market Closed -
Oslo Bors
15:45:00 09/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.7000 NOK | +40.56% |
|
0.00% | -49.28% |
| 09-03 | EXACT Therapeutics AS Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 06-30 | Exact Therapeutics to Delist from Euronext Growth Oslo in October | MT |
| Market Cap | 44.28M 4.7M 4.19M 3.88M 3.53M 6.63M 446M 6.74M 46.59M 18.32M 233M 17.65M 17.28M 745M | P/E 2024 |
-2.49x | P/E 2025 | -1x |
|---|---|---|---|---|---|
| Enterprise Value | 20.37M 2.16M 1.93M 1.79M 1.62M 3.05M 205M 3.1M 21.43M 8.43M 107M 8.12M 7.95M 343M | EV / Sales 2024 |
-
| EV / Sales 2025 | 1,074,437,000x |
| Free-Float |
28.08% | Yield 2024 * |
-
| Yield 2025 | - |
Oslo BorsNOK
| Markets | Quality | ||
|---|---|---|---|
Oslo Bors
| EXTX | Real-time | |
Deutsche Boerse AG
| 56F | Delayed |
| 1 day | +40.56% | ||
| Current month | -1.41% | ||
| 1 month | -10.83% | ||
| 3 months | -3.45% | ||
| 6 months | -54.25% | ||
| Current year | -49.28% |
| 1 month | 0.43 |  | 0.9 |
| Current year | 0.43 | | 2.7 |
| 1 year | 0.43 | | 2.7 |
| 3 years | 0.43 | | 15 |
| 5 years | 0.43 | | 21 |
| 10 years | 0.43 | | 53.59 |
| Manager | Title | Age | Since |
|---|---|---|---|
Per Walday
CEO | Chief Executive Officer | 66 | 05/06/2022 |
Svein Kvåle
COO | Chief Operating Officer | - | 31/12/2011 |
John Edminson
DFI | Director of Finance/CFO | - | 30/09/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 55 | 21/06/2018 | |
Anders Wold
CHM | Chairman | - | 07/06/2022 |
| Director/Board Member | 59 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 04/01/23 | Buy | Chairman | 2,500 | 0.0083% | ||
| 04/01/23 | Buy | Founder | 2,500 | 0.0083% | ||
| 04/01/23 | Buy | Chief Financial Officer | 2,500 | 0.0083% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +40.56% | 0.00% | -62.57% | -95.33% | 4.69M | |
| +1.52% | -7.16% | +51.66% | +67.41% | 65B | |
| +1.52% | +6.83% | +10.89% | +79.30% | 51.2B | |
| +0.30% | -0.46% | -0.03% | +61.89% | 51.19B | |
| -0.79% | +0.88% | +24.74% | +41.64% | 43.93B | |
| +0.33% | +5.61% | +16.16% | +133.23% | 41.96B | |
| +2.47% | -6.48% | +235.85% | +525.48% | 38.14B | |
| +2.16% | +10.36% | +18.92% | +59.70% | 33.24B | |
| -0.90% | -10.49% | +37.09% | +1.80% | 25.2B | |
| +1.60% | +2.21% | +27.96% | +28.00% | 22.5B | |
| Average | +4.83% | +0.50% | +36.07% | +90.31% | 37.24B | |
| Weighted average by Cap. | +0.89% | +0.04% | +45.30% | +112.07% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 0.06 0.01 0.01 0.01 0 0.01 0.59 0.01 0.06 0.02 0.31 0.02 0.02 0.99 |
| Net income | -52.33M -5.56M -4.96M -4.59M -4.17M -7.83M -527M -7.96M -55.05M -21.65M -275M -20.86M -20.42M -881M | -86.97M -9.24M -8.23M -7.63M -6.94M -13.01M -876M -13.23M -91.49M -35.98M -458M -34.66M -33.93M -1.46B |
| Net Debt | -98.89M -10.5M -9.36M -8.67M -7.89M -14.8M -996M -15.04M -104M -40.91M -521M -39.41M -38.59M -1.66B | -23.91M -2.54M -2.26M -2.1M -1.91M -3.58M -241M -3.64M -25.16M -9.89M -126M -9.53M -9.33M -402M |
Employees
11
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- EXTX Stock
Select your edition
All financial news and data tailored to specific country editions
